I-Meglitinides imithi yomlomo esetshenziselwa ukwelashwa uhlobo lwesifo sikashukela . Imithi kuleli klasini ihlanganisa iPrandin (repaglinide) ne-Starlix (nateglinide).
Yini i-Meglitinides Do
Emzimbeni womuntu, i-insulin ikhiqizwa ngamaseli akhethekile ema-pancreas. Lawa abizwa ngamaseli e-beta. Kubantu abanesifo sikashukela sohlobo lwesibili, noma i-pancreas ayikhiqizi ngokwanele i-insulin noma i-insulin eyenzayo ayisetshenziswanga kahle, okwenza amazinga kashukela egazi akwazi ukulawula.
I-Meglitinides ivuselela amangqamuzana e-beta ukuze akhiqize i-insulini engaphezulu, esiza umzimba ukuba uthuthukise kangcono i-glucose (ushukela) nokunciphisa amazinga kashukela egazini. Lesi sigaba esithile semithi senzelwe ukusiza ukuphuza okushukela egazini ngemva kokudla .
I-Meglitinides imishanguzo emifushane ewenzayo okusho ukuthi inengozi encane yokukhiqiza i-hypoglycemia. Kodwa-ke, uma le mithi ithathwa ngaphandle kokudla ingabangela ushukela ophansi wegazi .
Futhi, i-meglitinide kufanele ithathwe cishe imizuzu engu-15 ngaphambi kokudla futhi ngokuvamile imisiwe ukuba isetshenziswe kathathu nsuku zonke ngaphambi kokudla. Uma weqa ukudla, akufanele uthathe. Isikhathi semithi singavumela ukuhlelwa kokudla okuguquguqukayo kakhulu ngoba kuthathwa kuphela uma udla.
I-Meglitinide Engenzani
Ngenkathi i-meglitinides isiza ukukhiqiza i-insulini engaphezu kweziguli ezisekhiqiza ezinye kusukela kumaphakethe, azikwazi ngokunciphisa ngqo ushukela wegazi. Ngakho-ke, i-meglitinides ayifuni esikhundleni se-insulin futhi ayifanele iziguli ezine-type 1 yesifo sikashukela .
I-Meglitinides kufanele ilandelwe ngaso sonke isikhathi ngokuhambisana nezinguquko zokuphila, njengokudla nokuzivocavoca .
Umlando we-Meglitinides
I-Meglitinides ivunyiwe yi-FDA yokwelapha uhlobo lwesifo sikashukela kusukela ngo-1997. Ingasetshenziswa yedwa noma ihlanganiswe neminye imithi. Leli klasi lemithi libekezelela kahle kubantu asebekhulile abadinga usizo lokunciphisa isikhathi sabo sokudla ushukela wegazi.
I-Meglitinides nayo ingabiza.
Ucwaningo lubonisa ukuthi i-repaglinide ifaniswa nezinye izidakamizwa zokulwa nesifo sikashukela zokunciphisa ushukela wegazi. I-Nateglinide, kuyilapho isebenza, ingase ingasebenzi kangcono ekunciphiseni amazinga kashukela egazi kuneminye imithi elwa nesifo sikashukela.
Ubani Okungafanele Asebenzise i-Meglitinides
Abantu abane-type 1 (isifo sikashukela esibhekene ne-insulin) noma imithi ye-meglitinides akufanele bayisebenzise. Iziguli okwamanje ezibhekene nokucindezeleka ngokomzimba okubangelwa ukutheleleka, ukulimala, noma ukuhlinzwa kungase kudingeke ukuyeka okwesikhashana ukuthatha i-meglitinides.
Ngaphezu kwalokho, i-meglitinides kumele ithathwe kuphela ngokudla. Uma umuntu ephuthelwa ukudla, kufanele aphule umthamo.
Imiphumela emibi kanye Neengozi ze-Meglitinides
Ushukela ophansi wegazi (i-hypoglycemia) yindlela ejwayelekile kunazo zonke ye-meglitinides. Izimpawu ze-hypoglycemia zihlanganisa ukujuluka, ukuthuthumela, ukukhanya okuncane, nokudideka okunokwenzeka.
Umuntu othola i-hypoglycemia (ushukela wegazi ngaphansi kuka-70mg / dL) kufanele adle uhlobo oluthile lwe-glucose, njengama-ounces amane ejusi. Noma ubani othola izimpawu zesifo sikashukela , kufaka phakathi ukudideka noma ukulahlekelwa ulwazi, kufanele afune usizo lwezempilo ngokushesha. I-Meglitinides ingabangela nokuzuza isisindo .
Yini Okufanele Ngiyazi?
I-Meglitinides inekhono lokusebenzisana neminye imithi.
Kubalulekile kubantu abathatha ukuhlola yonke imishanguzo yabo yamanje nabahlinzeki babo bokunakekelwa kwezempilo kuqala.
Abantu abanesifo sikashukela kufanele baxoxe nabahlinzeki babo bezempilo ngaphambi kokuthatha noma yimiphi imithi engaphezu kwe-counter noma i-herbal supplements. Uma ungumuntu ovame ukweqa ukudla njalo, khona-ke le mithi cishe ayilungile kuwe, futhi.
> Imithombo:
I-Bolen, i-Shari. "Ukubuyekeza Okuhlelekile: Ukuphumelela Ngokuqhathanisa Nokuphepha Kwemithi Yomlomo Ye-Type 2 Diabetes Mellitus." Ama-Annal of Medicine Internal 147 (18 Septhemba 2007).
Bolen, Shari, et al. "Ukuphumelela kokuqhathanisa nokuphepha kwemithi yomlomo kubantu abadala abane-type 2 yesifo sikashukela." I-Agency for Research and Quality Quality: Imibiko. 15 Julayi 2007. UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu. 11 Sep 2007.
McCullouch, David K. "Sulfonylureas and Meglitinides ekuPhilweni kwesifo Sikashukela Mellitus." UpToDate.com. 2007. UpToDate. 7 Sep 2007 (ukubhalisa).